Sylvia Bort-Marti
Overview
Explore the profile of Sylvia Bort-Marti including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
205
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Bort-Marti A, Rowe F, Ruiz Sifre L, Ng S, Bort-Marti S, Ruiz Garcia V
Cochrane Database Syst Rev
. 2023 Mar;
3:CD006499.
PMID: 36916692
Background: The use of botulinum toxin as an investigative and treatment modality for strabismus is well reported in the medical literature. However, it is unclear how effective it is in...
2.
Lopez-Briz E, Ruiz Garcia V, Cabello J, Bort-Marti S, Carbonell Sanchis R
Cochrane Database Syst Rev
. 2022 Jul;
7:CD008462.
PMID: 35849083
Background: Intermittent locking of central venous catheters (CVCs) is undertaken to help maintain their patency and performance. There are systematic variations in care: some practitioners use heparin (at different concentrations),...
3.
Lopez-Briz E, Ruiz Garcia V, Cabello J, Bort-Marti S, Carbonell Sanchis R, Burls A
Cochrane Database Syst Rev
. 2018 Jul;
7:CD008462.
PMID: 30058070
Background: Intermittent locking of central venous catheters (CVCs) is undertaken to help maintain their patency. There are systematic variations in care: some practitioners use heparin (at different concentrations), whilst others...
4.
Ruiz-Garcia V, Lopez-Briz E, Carbonell-Sanchis R, Bort-Marti S, Gonzalvez-Perales J
J Cachexia Sarcopenia Muscle
. 2018 Mar;
9(3):444-452.
PMID: 29542279
In 1993, megestrol acetate (MA) was approved by the US Food and Drug Administration for the treatment of anorexia, cachexia, or unexplained weight loss in patients with acquired immunodeficiency syndrome....
5.
Ruiz Garcia V, Burls A, Cabello J, Vela Casasempere P, Bort-Marti S, Bernal J
Cochrane Database Syst Rev
. 2017 Sep;
9:CD007649.
PMID: 28884785
Background: Tumour necrosis factor (TNF)-alpha inhibitors are beneficial for the treatment of rheumatoid arthritis (RA) for reducing the risk of joint damage, improving physical function and improving the quality of...
6.
Lopez-Briz E, Ruiz Garcia V, Cabello J, Bort-Marti S, Carbonell Sanchis R, Burls A
Cochrane Database Syst Rev
. 2014 Oct;
(10):CD008462.
PMID: 25300172
Background: Heparin intermittent flushing is a standard practice in the maintenance of patency in central venous catheters. However, we could find no systematic review examining its effectiveness and safety. Objectives:...
7.
Ruiz Garcia V, Jobanputra P, Burls A, Cabello J, Vela Casasempere P, Bort-Marti S, et al.
Cochrane Database Syst Rev
. 2014 Sep;
(9):CD007649.
PMID: 25231904
Background: Tumour necrosis factor (TNF)-alpha inhibitors are beneficial for the treatment of rheumatoid arthritis (RA) in terms of reducing the risk of joint damage, improving physical function and improving quality...
8.
Ruiz Garcia V, Lopez-Briz E, Carbonell Sanchis R, Gonzalvez Perales J, Bort-Marti S
Cochrane Database Syst Rev
. 2013 Apr;
(3):CD004310.
PMID: 23543530
Background: This is an updated version of a previously published review in The Cochrane Library (2005, Issue 2) on 'Megestrol acetate for the treatment of anorexia-cachexia syndrome'. Megestrol acetate (MA)...